| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Korean J Crit Care Med > Volume 28(1); 2013 > Article
Korean Journal of Critical Care Medicine 2013;28(1): 17-24. doi: https://doi.org/10.4266/kjccm.2013.28.1.17
외과계중환자실 담당약사의 약물유해반응 예방에 대한 처방중재효과
강민경ㆍ김아정ㆍ조윤숙ㆍ김향숙ㆍ이혜숙ㆍ유용재*ㆍ이한나*ㆍ박규주†ㆍ박희평*
서울대학교병원 약제부, *마취통증의학과, †외과
Effect of Clinical Pharmacist Interventions on Prevention of Adverse Drug Events in Surgical Intensive Care Unit
Minkyong Kang, Ahjeong Kim, Yoonsook Cho, Hyangsook Kim, Hyesook Lee, Yong Jae Yu, Hannah Lee, Kyu Joo Park, Hee pyoung Park
1Department of Pharmacy, Seoul National University Hospital, Seoul, Korea.
2Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul, Korea. hppark@snu.ac.kr
3Department of Surgery, Seoul National University Hospital, Seoul, Korea.
ABSTRACT
BACKGROUND: A pharmacist's participation in medical rounds in intensive care unit (ICU) is becoming popular nowadays. In this study, we investigated the effect of pharmacologic intervention by a pharmacist's participation in medical round in ICU on prevention of adverse drug events (ADEs). METHODS: From March 2011 to July 2011, the intervention data were obtained by participating in medical round two or three times a week, and by reviewing electronic medical records of patients admitted to surgical ICU. The incidence, cause, and type of ADEs were noted, respectively. Expected cost avoidance was calculated from interventions, which were considered to be preventive of ADEs. The acceptance rate of pharmacologic interventions was noted. RESULTS: Among 2781 patients, a total of 159 intervention data were collected in 90 patients. Recommendation for drug dosage adjustment or monitoring in patients with potential overdose and sub-therapeutic dose made up 82% of the total interventions. In 8% of interventions, initiation of drug therapy was recommended. 83% of the interventions were accepted and the acceptance rate of interventions within 24 hrs was 58%. The rate of the interventions, which were considered to be preventive of ADEs was 62%. Expected cost reduction obtained by preventing ADEs was 25,867,083 Won during a 5-month period. CONCLUSIONS: A pharmacist's participation in physician rounds in ICU was associated with prevention of ADEs and subsequent reduction of the cost in drug therapy.
Key Words: adverse drug events; clinical pharmacist; economics; intensive care unit; interventions
Editorial Office
#805-806, Yongseong Biztel, 109 Hangang-daero, Yongsan-gu, Seoul 04376, Korea
TEL: +82-2-2077-1533   FAX: +82-2-2077-1535   E-mail: acc@accjournal.org
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Society of Critical Care Medicine. All rights reserved.                 developed in m2community
Close layer
prev next